Rabbit Recombinant Monoclonal Guanine N6-methyladenosine (Gm6A) antibody. Suitable for FRET, Dot and reacts with Nucleic Acid samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
FRET | Dot | |
---|---|---|
Nucleic Acid | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Nucleic Acid | Dilution info 4 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Nucleic Acid | Dilution info 1/500 | Notes - |
Guanine N6-methyladenosine, Gm6A
Rabbit Recombinant Monoclonal Guanine N6-methyladenosine (Gm6A) antibody. Suitable for FRET, Dot and reacts with Nucleic Acid samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Gm6A also known as N6-methyladenosine (m6A) methyltransferase is an essential component of the RNA modification machinery. It plays a critical role in post-transcriptional regulation. The protein mass of Gm6A is approximately 86 kDa. It is widely expressed in mammalian cells particularly prominent in brain and liver tissues. Gm6A facilitates the methylation of adenosine residues on RNA molecules influencing RNA stability splicing and export.
Gm6A functions in the regulation of RNA metabolism. As an important player in epitranscriptomics it is part of the methyltransferase complex along with METTL3 and METTL14. This complex modifies messenger RNA to control gene expression and ensure proper cellular responses to various stimuli. The modification process governed by Gm6A is essential for maintaining RNA dynamic functions involving feedback loops where altered RNA impacts protein synthesis and cell signaling pathways.
Multiple cellular processes rely on the functions of Gm6A methylation. It's involved in the mRNA processing pathway contributing to splicing and alternative polyadenylation. Gm6A interacts with proteins like YTHDF1 and YTHDF2 which mediate mRNA translation and degradation. Through these pathways Gm6A supports cell differentiation and stress responses embedding itself in the larger network of gene expression regulation.
Gm6A regulation has implications in cancer and neurological disorders. Altered m6A methylation patterns correlate with tumorigenesis in cancers including leukemia and glioblastoma. The aberrant methylation affects proteins like FTO which is an m6A demethylase potentially driving oncogenic pathways. In neurological contexts disruptions in m6A methylation play a role in neurodevelopmental disorders with implications for proteins such as RBM15 that are involved in cognitive functions and brain development.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Dot blot analysis of Gm6A using ab315152 at 1:500 (1ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1:20,000 dilution.
All lanes: Dot Blot - Anti-Gm6A antibody [EPR25802-21] (ab315152) at 1/500 dilution
Lane 1: HeLa total RNA
Lane 2: HeLa mRNA
All lanes: Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Exposure time: 32s
A FRET-based assay was performed using 25nm of each biotinylated oligos and ab315152 at a concentration range of 0.001-4.000 µg/mL
Dot blot analysis of Gm6A using ab315152 at 1:500 (1ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1:20,000 dilution.
All lanes: Dot Blot - Anti-Gm6A antibody [EPR25802-21] (ab315152) at 1/500 dilution
Lane 1: A-oligo with AdvanBlock
Lane 2: Am-oligo with AdvanBlock
Lane 3: m6A-oligo with AdvanBlock
Lane 4: m6, 6A-oligo with AdvanBlock
Lane 5: m6Am-oligo with AdvanBlock
Lane 6: G-oligo with AdvanBlock
Lane 7: Gm6A-oligo with AdvanBlock
Lane 8: Am6A-oligo with AdvanBlock
Lane 9: Cm6A-oligo with AdvanBlock
Lane 10: m8A-oligo with AdvanBlock
Lane 11: m1A-oligo with AdvanBlock
Lane 12: m1G-oligo with AdvanBlock
Lane 13: m2G-oligo with AdvanBlock
Lane 14: m2, 2G-oligo with AdvanBlock
All lanes: Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Exposure time: 10s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com